mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-09 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-09 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-08 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-08 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-08 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-08 |